ロード中...

Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma

Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s. However, MM was first-in line to benefit from the wave of checkpoint inhibitors (CPI), which shifted the focus of immunotherapy al...

詳細記述

保存先:
書誌詳細
出版年:J Immunother Cancer
主要な著者: Borch, Troels Holz, Andersen, Rikke, Ellebaek, Eva, Met, Özcan, Donia, Marco, Marie Svane, Inge
フォーマット: Artigo
言語:Inglês
出版事項: BMJ Publishing Group 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7398110/
https://ncbi.nlm.nih.gov/pubmed/32747469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000668
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!